Elevations in Liver Transaminases in COVID-19: (How) Are They Related?

Liver involvement in COVID-19 is not yet well-understood, but elevations in liver transaminases have been described to occur in 14–53% of the cases and are more frequently seen in severe disease. This cross-sectional study explored the relationship between the elevations in liver transaminases and i...

Full description

Bibliographic Details
Main Authors: Henrique Pott-Junior, Natália Queiroz Prado Bittencourt, Silvana F. G. Chacha, Rafael Luís Luporini, Marcia Regina Cominetti, Fernanda de Freitas Anibal
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.705247/full
_version_ 1818718130693734400
author Henrique Pott-Junior
Natália Queiroz Prado Bittencourt
Silvana F. G. Chacha
Rafael Luís Luporini
Rafael Luís Luporini
Marcia Regina Cominetti
Fernanda de Freitas Anibal
Fernanda de Freitas Anibal
author_facet Henrique Pott-Junior
Natália Queiroz Prado Bittencourt
Silvana F. G. Chacha
Rafael Luís Luporini
Rafael Luís Luporini
Marcia Regina Cominetti
Fernanda de Freitas Anibal
Fernanda de Freitas Anibal
author_sort Henrique Pott-Junior
collection DOAJ
description Liver involvement in COVID-19 is not yet well-understood, but elevations in liver transaminases have been described to occur in 14–53% of the cases and are more frequently seen in severe disease. This cross-sectional study explored the relationship between the elevations in liver transaminases and inflammatory parameters in 209 adults with COVID-19. Demographic and clinical data, serum levels of inflammatory cytokines and liver aminotransferases were analyzed. Three groups were formed according to the liver transaminase abnormalities: (I) Normal transaminases, (II) Borderline transaminases elevation, and (III) Mild to severe transaminases elevation. Altered liver transaminases were directly related to disease severity, showing association with the NEWS2 score at admission and greater need for ICU or death. Moreover, higher levels of IL-2 and CRP were associated with borderline transaminases elevations, whereas higher levels of IL-10 and Neutrophil to Lymphocyte ratio were associated with mild to severe transaminases elevation. These results reinforce the importance of liver transaminases in patients with COVID-19 as a complementary marker for disease severity and also point to them as a parameter reflecting the continuous dynamics between viral infection and the immune response.
first_indexed 2024-12-17T19:46:10Z
format Article
id doaj.art-6652d011aa334344aaa3cca4a6b4898c
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-17T19:46:10Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-6652d011aa334344aaa3cca4a6b4898c2022-12-21T21:34:52ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-07-01810.3389/fmed.2021.705247705247Elevations in Liver Transaminases in COVID-19: (How) Are They Related?Henrique Pott-Junior0Natália Queiroz Prado Bittencourt1Silvana F. G. Chacha2Rafael Luís Luporini3Rafael Luís Luporini4Marcia Regina Cominetti5Fernanda de Freitas Anibal6Fernanda de Freitas Anibal7Department of Medicine, Federal University of São Carlos, São Carlos, BrazilDepartment of Medicine, Federal University of São Carlos, São Carlos, BrazilDepartment of Medicine, Federal University of São Carlos, São Carlos, BrazilDepartment of Medicine, Federal University of São Carlos, São Carlos, BrazilBiotechnology Graduate Program, Federal University of São Carlos, São Carlos, BrazilDepartment of Gerontology, Federal University of São Carlos, São Carlos, BrazilBiotechnology Graduate Program, Federal University of São Carlos, São Carlos, BrazilDepartment of Biological Sciences Parasitology, Federal University of São Carlos, São Carlos, BrazilLiver involvement in COVID-19 is not yet well-understood, but elevations in liver transaminases have been described to occur in 14–53% of the cases and are more frequently seen in severe disease. This cross-sectional study explored the relationship between the elevations in liver transaminases and inflammatory parameters in 209 adults with COVID-19. Demographic and clinical data, serum levels of inflammatory cytokines and liver aminotransferases were analyzed. Three groups were formed according to the liver transaminase abnormalities: (I) Normal transaminases, (II) Borderline transaminases elevation, and (III) Mild to severe transaminases elevation. Altered liver transaminases were directly related to disease severity, showing association with the NEWS2 score at admission and greater need for ICU or death. Moreover, higher levels of IL-2 and CRP were associated with borderline transaminases elevations, whereas higher levels of IL-10 and Neutrophil to Lymphocyte ratio were associated with mild to severe transaminases elevation. These results reinforce the importance of liver transaminases in patients with COVID-19 as a complementary marker for disease severity and also point to them as a parameter reflecting the continuous dynamics between viral infection and the immune response.https://www.frontiersin.org/articles/10.3389/fmed.2021.705247/fullinflammationinterleukin-2interleukin-10lymphocytesSARS-CoV-2hepatitis
spellingShingle Henrique Pott-Junior
Natália Queiroz Prado Bittencourt
Silvana F. G. Chacha
Rafael Luís Luporini
Rafael Luís Luporini
Marcia Regina Cominetti
Fernanda de Freitas Anibal
Fernanda de Freitas Anibal
Elevations in Liver Transaminases in COVID-19: (How) Are They Related?
Frontiers in Medicine
inflammation
interleukin-2
interleukin-10
lymphocytes
SARS-CoV-2
hepatitis
title Elevations in Liver Transaminases in COVID-19: (How) Are They Related?
title_full Elevations in Liver Transaminases in COVID-19: (How) Are They Related?
title_fullStr Elevations in Liver Transaminases in COVID-19: (How) Are They Related?
title_full_unstemmed Elevations in Liver Transaminases in COVID-19: (How) Are They Related?
title_short Elevations in Liver Transaminases in COVID-19: (How) Are They Related?
title_sort elevations in liver transaminases in covid 19 how are they related
topic inflammation
interleukin-2
interleukin-10
lymphocytes
SARS-CoV-2
hepatitis
url https://www.frontiersin.org/articles/10.3389/fmed.2021.705247/full
work_keys_str_mv AT henriquepottjunior elevationsinlivertransaminasesincovid19howaretheyrelated
AT nataliaqueirozpradobittencourt elevationsinlivertransaminasesincovid19howaretheyrelated
AT silvanafgchacha elevationsinlivertransaminasesincovid19howaretheyrelated
AT rafaelluisluporini elevationsinlivertransaminasesincovid19howaretheyrelated
AT rafaelluisluporini elevationsinlivertransaminasesincovid19howaretheyrelated
AT marciareginacominetti elevationsinlivertransaminasesincovid19howaretheyrelated
AT fernandadefreitasanibal elevationsinlivertransaminasesincovid19howaretheyrelated
AT fernandadefreitasanibal elevationsinlivertransaminasesincovid19howaretheyrelated